Changshan Pharmaceutical announced that the company participated in the 12th batch of centralized procurement bidding for state-organized drugs. The product heparin sodium injections will be selected for this centralized procurement. The specifications are 0.2 ml: 5000 IU and 0.3 ml: 7500 IU. The product achieved sales revenue of 120 million yuan in 2025, accounting for 13.71% of the company's 2025 revenue. The procurement cycle starts from the date of execution of the selection results to December 31, 2029. If a procurement contract is signed and implemented later, it will help promote sales of related products.

Zhitongcaijing · 2d ago
Changshan Pharmaceutical announced that the company participated in the 12th batch of centralized procurement bidding for state-organized drugs. The product heparin sodium injections will be selected for this centralized procurement. The specifications are 0.2 ml: 5000 IU and 0.3 ml: 7500 IU. The product achieved sales revenue of 120 million yuan in 2025, accounting for 13.71% of the company's 2025 revenue. The procurement cycle starts from the date of execution of the selection results to December 31, 2029. If a procurement contract is signed and implemented later, it will help promote sales of related products.